removed anti-miilleriaD activity from medium containing bioactive AHH. The monoclonal antibody also blocked anti-mllilerian activity of calf fetal testicular tissue. indicating that it is directed againat the biologically active portion of the AHH molecule . These results prove the identity between AHH and its biochemical marker. and should greatly hasten the isolation and quant itative assay of the hormone. We have detected 3 variant polymorphic 8g1 II restriction patterns which are traceable through pedigrees and can be used to test for physical linkage of HGH deficiency to HGH/HPL gene cluster variation. All HGH/HPL restriction patterns found in hypopituitary individuals were also found in normals. Thus. there were no instances in which HGH deficiency could be attributed to deletion of an HGH gene. Also . discordance for 8g1 II restriction patterns in 2 siblings with autosomal recessive HGH deficiency provided evidence against HGH gene mutation as the cause of the disease.
F.J.BOLLAND. D.Di8ATTISTA* and L.LUNA* Hospital for Sick Children, U of Tbronto,Canada Somat01lll!din in the rhesus monkey fetus To assesa the role of aomatomedin in the maturing fetus, a RIA waa developed for Multiplication Stimulating Activity (MSA), a major aomatomedin. Purified HSA was conjugated to hemocyanin and specific antiserum induced in rabbits. In the RIA there was parallel diaplacement with unlabelled HSA and acid-extracted human or rhea us monkey serum. There waa no croaa-reactivity with phyaiological concentrationa of inaulin or with the other aomatomedina. Immunoreactive HSA(I-MSA) in acromegalic aerum extracta waa approximately twice that of normal controla, while levels were reduced in growth hormone (GH) deficiency. I-HSA in pooled extracta from aera of 5 adult male monkeys was 84.0 ng/ml. Fetal aamplea were obtained from rhesus monkeys through catheterized interplacental veaaela. At 90 days geatation (term 165 days).
I-HSA in 5 fetusea was 70.2 + 21.0 ng/ml (mean + SEH). and at 160 daya. 172.0 + 34.3 ng/al-(P <o.05).Correaponding GH levels were 50.7 + 2.0 ng/ml and 24.3 + 2.3 ng/ml (P< O.ool)(reported 6lat.End. Soc. 1979. Abat.601).-Because of marked variability,the mean level of I-HSA in day-old neonatea was not aignificantly different from fetal values. The riaing levela of I-HSA during the latter half of geatation in theae studiea auggeat that:(l)somatomedins may play an importsnt role in fetal growth; (2) so..tomedin may exert feedbsck inhibition on GB secretion during this period. To study t he re gulat ion of the l i ver somatogenic (GHl and l actogenic (PRLl receptors during dev elopment. their number and affinity were det ermined at weekl y intervals in male and female rats.
the results were correlated with growth velocity and the hormone I changes induced by puberty. The GH and PRL binding sites of liver homogenates were enalyzed using 12SI-bovine and 125I-ov1ne PRL.
In the males. the PRL receptors were present at day 21 [2.0±O.5 pmoles/liver, mean±1 S.E., n=5). reached a peak at day 35 [9±2. n·5). then decreased to be undetectable at day 63. In the females. their evolution was similar until day 35, thereafter. a four-fold in crease occurred. a plateau being reached at day 49 (52±6, n=5).
The number of GH receptors exhibited a progressive increase in males (da y 21: 9±1. n=5, day 120: 47±9. n=5) and females (day 21: 5±1.n=5. day 120 : 73±10. n=5J . At the time of pubertal growth spurt th e me a n number of GH receptors was equal to 50% o f the adult valu es. The aff init y (Ka) of GH and PRL receptor s s howed no significa nt change wit h ege and se x [bGH: O.51 ±0 .03x10 9 M -I , oPRL: 0.93± 0. 06x10 9 M-1,n · 60). Thes e data suggest thet in t he male. the puberta l rise of t estos terone inhibi ts t he PRL receptors . whi le in the female the surge of estradiol induces 6 sharp increase of these receptors . The GH receptors do not appear to be regulated by gonada l steroids. Serum IGF levels were assayed, after acid extraction, in 26 giris and 32 boys (aged 1 -22) whose height for their age exceed 3 SO, by a radiollgand assay using human IaF (gift from Dr Zapf. ZUrich) and a specific binding proteIn produced by rat liver in culture. Results are expressed in relatIon to a pool of normai adult serum arbitrarily assigned a value of 1 U/ml. 1) ror the 15 children aged 1-10, the mean IGr level was 0.83 ! 0.09 (SEH) U/ml which Is significantly higher than that for normal children (0.59 ! 0.05, n =29) (p <0.01) . 2) In the 21 10-15 year-old, IGr levels (1.35 t 0.09) were higher than controls (1.05~0.08, n =18) (p< 0.01). 7 girls and 1 boy had levels (1.52 -2.46) comparable to those of untreated acromegalies. CH levels 60 min after glucose load (30 g/m 2) were < 5 ng/ml In 11 subjects studied. 3) In the 22 patients over 15, IaF ievels (1.09 t 0.07) Were similar to those of normal adults (1.06 : 0.03 U/ml). 4) In 10 girls under etttnyloestradiol (200-300 fg/dao} for a prognosis of a final height exceeding 180 em, parallel with the decrease in growth, there was a slow but progressive drop in IaF levels (means: 1.49 U/ml after 3 months, 1.08 after 1 year). The abnormally high IGF levels seen with idiopathic tall stature and the drop accompanying oestrogen therapy suggest a direct relation between IaF production and growth rate. The return to normai leveis once ossification is compiete suggests a reguiatory disorder durinq the growth period.
